Sonnet BioTherapeutics (SONN) Free Cash Flow (2010 - 2025)
Sonnet BioTherapeutics (SONN) free cash flow from Jun 30, 2010 to Sep 30, 2025. The TTM Sonnet BioTherapeutics (SONN) free cash flow is -$13M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Sonnet BioTherapeutics (SONN) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +49.01% |
| 3 Years TTM | -22.61% |
| 5 Years TTM | +2.83% |
| 10 Years TTM | +8.88% |
| All Time TTM | +31.46% |
Annual Free Cash Flow change of Sonnet BioTherapeutics (SONN)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$13M | +49.01% |
| 2024 | -$8.61M | -59.65% |
| 2023 | -$21M | -22.93% |
| 2022 | -$28M | +22.79% |
| 2021 | -$23M | +43.72% |
| 2020 | -$16M | +247.12% |
| 2019 | -$4.52M | +60.85% |
| 2018 | -$2.81M | +19.57% |
| 2017 | -$2.35M | +38.24% |
| 2016 | -$1.70M | -76.29% |
| 2015 | -$7.17M | +139.00% |
| 2014 | -$3M | -52.83% |
| 2013 | -$6.36M | +79.15% |
| 2012 | -$3.55M | +157.25% |
| 2011 | -$1.38M | +81.58% |
| 2010 | -$760K | N/A |
Comparison Sonnet BioTherapeutics (SONN) five years free cash flow CAGR with competitors
Sonnet BioTherapeutics (SONN) five years free cash flow CAGR is -1.45%.